This company has been marked as potentially delisted and may not be actively trading. Sinovac Biotech (SVA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendHeadlinesOptions ChainTrendsBuy This Stock SVA vs. MIRM, XENE, IBRX, ARWR, LGND, APLS, TWST, VCEL, DNLI, and KNSAShould you be buying Sinovac Biotech stock or one of its competitors? The main competitors of Sinovac Biotech include Mirum Pharmaceuticals (MIRM), Xenon Pharmaceuticals (XENE), ImmunityBio (IBRX), Arrowhead Pharmaceuticals (ARWR), Ligand Pharmaceuticals (LGND), Apellis Pharmaceuticals (APLS), Twist Bioscience (TWST), Vericel (VCEL), Denali Therapeutics (DNLI), and Kiniksa Pharmaceuticals International (KNSA). These companies are all part of the "med - biomed/gene" industry. Sinovac Biotech vs. Its Competitors Mirum Pharmaceuticals Xenon Pharmaceuticals ImmunityBio Arrowhead Pharmaceuticals Ligand Pharmaceuticals Apellis Pharmaceuticals Twist Bioscience Vericel Denali Therapeutics Kiniksa Pharmaceuticals International Sinovac Biotech (NASDAQ:SVA) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership. Is SVA or MIRM more profitable? Sinovac Biotech has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -20.39%. Sinovac Biotech's return on equity of 0.00% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Sinovac BiotechN/A N/A N/A Mirum Pharmaceuticals -20.39%-33.63%-11.50% Which has more volatility and risk, SVA or MIRM? Sinovac Biotech has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Which has preferable valuation and earnings, SVA or MIRM? Mirum Pharmaceuticals has lower revenue, but higher earnings than Sinovac Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSinovac Biotech$448.27M1.44-$99.92MN/AN/AMirum Pharmaceuticals$336.89M7.34-$87.94M-$1.61-31.01 Does the media refer more to SVA or MIRM? In the previous week, Sinovac Biotech and Sinovac Biotech both had 6 articles in the media. Mirum Pharmaceuticals' average media sentiment score of 0.50 beat Sinovac Biotech's score of 0.00 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sinovac Biotech 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mirum Pharmaceuticals 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend SVA or MIRM? Mirum Pharmaceuticals has a consensus target price of $65.50, suggesting a potential upside of 31.18%. Given Mirum Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Mirum Pharmaceuticals is more favorable than Sinovac Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sinovac Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryMirum Pharmaceuticals beats Sinovac Biotech on 8 of the 12 factors compared between the two stocks. Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSinovac BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$644.66M$2.92B$5.56B$9.05BDividend YieldN/A2.44%5.24%4.01%P/E RatioN/A21.5627.6120.24Price / Sales1.44278.20416.87118.48Price / Cash38.9542.7336.8958.10Price / Book0.057.518.035.67Net Income-$99.92M-$55.14M$3.18B$249.21M Sinovac Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASinovac BiotechN/A$6.47flatN/AN/A$644.66M$448.27M0.003,261High Trading VolumeMIRMMirum Pharmaceuticals3.7349 of 5 stars$50.89-0.4%$65.50+28.7%+47.4%$2.53B$336.89M-31.61140News CoverageXENEXenon Pharmaceuticals2.918 of 5 stars$31.30-3.4%$54.82+75.1%-3.9%$2.49B$9.43M-9.69210IBRXImmunityBio1.8549 of 5 stars$2.64-2.2%$12.25+364.0%-57.0%$2.38B$14.74M-4.55590Negative NewsGap UpARWRArrowhead Pharmaceuticals3.9435 of 5 stars$15.80-1.7%$43.71+176.7%-33.1%$2.22B$3.55M-11.29400LGNDLigand Pharmaceuticals4.8111 of 5 stars$113.68-0.4%$146.14+28.6%+38.3%$2.20B$167.13M-15.9780News CoverageAPLSApellis Pharmaceuticals4.428 of 5 stars$17.31-0.7%$40.05+131.4%-49.2%$2.19B$775.84M-9.67770Trending NewsAnalyst ForecastAnalyst RevisionTWSTTwist Bioscience4.4703 of 5 stars$36.79+2.4%$50.40+37.0%-20.6%$2.15B$312.97M-11.32990Positive NewsVCELVericel2.8497 of 5 stars$42.55+2.0%$61.14+43.7%-7.0%$2.10B$237.22M1,418.81300News CoveragePositive NewsDNLIDenali Therapeutics4.6377 of 5 stars$13.99-0.8%$33.71+141.0%-31.0%$2.05B$330.53M-5.24430Positive NewsKNSAKiniksa Pharmaceuticals International3.2718 of 5 stars$27.67-1.3%$38.80+40.2%+45.8%$2.05B$423.24M-110.68220 Related Companies and Tools Related Companies MIRM Alternatives XENE Alternatives IBRX Alternatives ARWR Alternatives LGND Alternatives APLS Alternatives TWST Alternatives VCEL Alternatives DNLI Alternatives KNSA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SVA) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinovac Biotech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinovac Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SVA Stock Alerts